| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $291.8M | +43.7% |
| R&D Expense | $31.2M | +21.9% |
| SG&A Expense | $182.4M | +11.6% |
| Operating Income | $24.9M | +174.0% |
| Pre-tax Income | $554K | +101.0% |
| Income Tax | $0 | +100.0% |
| Net Income | $554K | +101.0% |
| EPS (Basic) | $0.00 | +100.0% |
| EPS (Diluted) | $0.00 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $111.0M | +55.0% |
| Accounts Receivable | $51.0M | +26.3% |
| Inventory | $68.7M | +42.5% |
| Current Assets | $240.3M | +43.3% |
| Total Assets | $383.5M | +18.7% |
| Current Liabilities | $109.6M | +9.1% |
| Long-term Debt | $220.3M | -5.1% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $28.6M | +177.4% |
| Investing Cash Flow | -$696K | -114.3% |
| Financing Cash Flow | $11.4M | -68.5% |
| +100.0% |
| Total Liabilities |
| $369.8M |
| +4.9% |
| Stockholders' Equity | $13.7M | +146.2% |